Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Companion Animal Postoperative Pain Management Therapeutics Market by Product (Anesthetics, NSAIDs, Opioids), Animal Type (Canine, Feline) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 149.46 million in 2024, at a CAGR 10.05% to reach USD 265.74 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Companion ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Polycystic Ovarian Syndrome Treatment Market by Drug Class (Anti-Depressants, Anti-Obesity, Insulin Sensitizing Agents), Surgery (Laparoscopic Ovarian Drilling, Ovarian Wedge Resection), Distribution Channel - Global Forecast 2024-2030
... at USD 3.25 billion in 2023 and expected to reach USD 3.45 billion in 2024, at a CAGR 6.63% to reach USD 5.09 billion by 2030. Global Polycystic Ovarian Syndrome Treatment Market FPNV Positioning Matrix ... Read More
-
Tuberculosis Drugs Market by Disease (Active TB, Latent TB), Drug Class (Combination Drugs, First-line Anti-TB Drugs, Second-line Anti-TB Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 6.28% to reach USD 2.95 billion by 2030. Global Tuberculosis Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2024-2030
... Market size was estimated at USD 19.14 billion in 2023 and expected to reach USD 21.35 billion in 2024, at a CAGR 11.88% to reach USD 42.02 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Pharmacogenomics Market by Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Application (Drug Discovery, Neurology, Oncology) - Global Forecast 2024-2030
... 9.10 billion in 2024, at a CAGR 5.97% to reach USD 12.73 billion by 2030. Global Pharmacogenomics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Pharmacogenomics Market. It offers a ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Global Forecast 2024-2030
... 4.77 billion in 2023 and expected to reach USD 5.03 billion in 2024, at a CAGR 5.39% to reach USD 6.90 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Asia Pacific Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... (Hospital & Clinics and Ambulatory Surgical Center) The Asia Pacific glioma treatment market is expected to grow from US$ 754.97 million in 2022 to US$ 1,538.88 million by 2030. It is estimated to grow at ... Read More
-
Fetal Bovine Serum Market by Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum), Application (Cell Culture Media, Diagnostics, Drug Discovery), End-User - Global Forecast 2024-2030
... 1.02 billion in 2023 and expected to reach USD 1.08 billion in 2024, at a CAGR 6.44% to reach USD 1.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Microbiome Therapeutics Market by Type (FMT, Microbiome Drugs), Application (C. difficile, Crohn’s disease, Diabetes) - Global Forecast 2024-2030
... USD 156.40 million in 2024, at a CAGR 23.77% to reach USD 564.82 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Microbiome Therapeutics Market. It offers a comprehensive ... Read More
-
Gout Therapeutics Market by Drug Class (Colchicine, Corticosteroids, NSAIDs), Treatment (Uricosuria Medication, Xanthine Oxidase Inhibitor), Route of Administration, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 3.05 billion in 2024, at a CAGR 10.95% to reach USD 5.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gout Therapeutics ... Read More
-
Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2024-2030
... reach USD 1.48 billion in 2024, at a CAGR 10.91% to reach USD 2.77 billion by 2030. Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically ... Read More
-
Infectious Disease Therapeutics Market by Drug (Antibiotics, Antifungal Drugs, Antiparasitic Drugs), Route of Administration (Intravenous, Oral, Topical), Disease, Distribution Channel, End-User - Global Forecast 2024-2030
... 116.21 billion in 2023 and expected to reach USD 121.27 billion in 2024, at a CAGR 4.41% to reach USD 157.28 billion by 2030. Global Infectious Disease Therapeutics Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), End-use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
... reach USD 10.81 billion in 2024, at a CAGR 8.44% to reach USD 17.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Therapeutics Market. It offers a ... Read More
-
South & Central America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... End User (Hospital & Clinics and Ambulatory Surgical Center) The South & Central America glioma treatment market is expected to grow from US$ 117.14 million in 2022 to US$ 227.74 million by 2030. It is ... Read More
-
Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 30.76 billion in 2024, at a CAGR 4.11% to reach USD 38.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Therapeutics ... Read More
-
Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors), Route of Administration (Intravitreal Injections, Oral Administration), Indication - Global Forecast 2024-2030
... estimated at USD 8.49 billion in 2023 and expected to reach USD 9.01 billion in 2024, at a CAGR 8.85% to reach USD 15.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Osteoarthritis Therapeutics Market by Anatomy (Hand Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis), Drug Type (Analgesics, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs), Route of Administration, Purchasing Pattern, Distribution Channel
... estimated at USD 7.90 billion in 2023 and expected to reach USD 8.69 billion in 2024, at a CAGR 10.39% to reach USD 15.78 billion by 2030. Global Osteoarthritis Therapeutics Market FPNV Positioning Matrix The ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Microplate Reader Market (Product Type: Single-mode Readers, and Multi-mode Readers, and Application: Drug Discovery, Genomics & Proteomics Research, Clinical Diagnostics, and Others) - Global Industry Analysis, Share, Share, Growth, Trends, and Forecast 2023-2031
... Market – Scope of Report TMR’s report on the global microplate reader market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Microplate Systems Market by Product (Microplate Pipetting Systems & Dispensers, Microplate Washers, Multi-Mode Microplate Readers), Application (Clinical Diagnostics, Drug Discovery, Genomics & Proteomics Research), End-User - Global Forecast 2024-2030
... estimated at USD 1.11 billion in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 5.25% to reach USD 1.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Global Forecast 2024-2030
... was estimated at USD 5.21 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.23% to reach USD 8.49 billion by 2030. Global Bladder Cancer Therapeutics Market FPNV Positioning ... Read More
-
Automated Liquid Handling Technologies Market by Technology (Automated Pipetting Systems, Automated Sample Preparation Systems, Dispensers & Dilutors), Application (Clinical Chemistry, Drug Discovery & Development, Genomics & Sequencing), End-User - Globa
... Handling Technologies Market size was estimated at USD 2.49 billion in 2023 and expected to reach USD 2.90 billion in 2024, at a CAGR 9.80% to reach USD 4.79 billion by 2030. FPNV Positioning Matrix ... Read More
-
Europe Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), and End User (Hospital & Clinics and Ambulatory Surgical Center)
... & Clinics and Ambulatory Surgical Center) The Europe glioma treatment market is expected to grow from US$ 959.99 million in 2022 to US$ 1,905.10 million by 2030. It is estimated to grow at a CAGR ... Read More
Research Assistance
